drugset / Trial / NCT05461456

Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%

NCT05461456

NaSingle-groupOpen-labelTreatment

Summary

The investigational lotion is envisaged as an short- and long term "Ease \& Prevent" monotherapy for adults and children with mild to moderate eczema. With itch representing the most burdensome symptom in eczema, the main objectives with the lotion is fast and efficient itch relief, high tolerability, and high short- and long term safety. This phase 1 study aims to monitor skin tolerability, and how much of the active compound that is absorbed to the bloodstream.

Timeline

Start
2022-04-01
Primary completion
2022-10-16
Completion
2022-10-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexofenadine Unknown 1 % Topical
Subject Fexofenadine Unknown 11 g Topical